Chitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin
- PMID: 18618466
- DOI: 10.1002/jbm.b.31161
Chitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin
Abstract
The purpose of this work was to investigate chitosan-N-acetyl-L-cysteine (chitosan-NAC) nanoparticles as a potential carrier system for the nasal delivery of insulin. For the study, we used insulin-loaded chitosan-NAC nanoparticles (140-210 nm in diameter) prepared by in situ gelation with tripolyphosphate (TPP), with positive zeta potential values of +19.5-31.7 mV and insulin loading capacities of 13-42%. The physicochemical properties of the nanoparticles were affected by the number of thiol groups present. Mucoadhesive properties, which were evaluated by measuring the in vitro absorbed mass of mucin, of chitosan-NAC nanoparticles were >1.8-fold that of unmodified chitosan nanoparticles. In aqueous solution, chitosan-NAC nanoparticles exhibited fast swelling behavior. Insulin was released from chitosan-NAC nanoparticles in vitro in an initial burst followed by slow release. Intranasal administration of chitosan-NAC nanoparticles in rats enhanced the absorption of insulin by the nasal mucosa compared with unmodified chitosan nanoparticles and control insulin solution. In light of these observations, the novel thiolated chitosan nanoparticles represent a promising vehicle for nasal insulin administration.
(c) 2008 Wiley Periodicals, Inc.
Similar articles
-
Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles.Eur J Pharm Biopharm. 2008 Mar;68(3):526-34. doi: 10.1016/j.ejpb.2007.08.009. Epub 2007 Aug 16. Eur J Pharm Biopharm. 2008. PMID: 17881202
-
Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.Int J Pharm. 2012 May 30;428(1-2):164-70. doi: 10.1016/j.ijpharm.2012.02.044. Epub 2012 Mar 5. Int J Pharm. 2012. PMID: 22421322
-
Insulin-loaded mucoadhesive nanoparticles based on mucin-chitosan complexes for oral delivery and diabetes treatment.Carbohydr Polym. 2020 Feb 1;229:115506. doi: 10.1016/j.carbpol.2019.115506. Epub 2019 Nov 4. Carbohydr Polym. 2020. PMID: 31826394
-
PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.Mol Pharm. 2016 Sep 6;13(9):2923-40. doi: 10.1021/acs.molpharmaceut.6b00335. Epub 2016 Jun 22. Mol Pharm. 2016. PMID: 27286558
-
Enhancement of nasal absorption of insulin using chitosan nanoparticles.Pharm Res. 1999 Oct;16(10):1576-81. doi: 10.1023/a:1018908705446. Pharm Res. 1999. PMID: 10554100
Cited by
-
Sodium Acetate Coated Tenofovir-Loaded Chitosan Nanoparticles for Improved Physico-Chemical Properties.Pharm Res. 2016 Feb;33(2):367-83. doi: 10.1007/s11095-015-1795-y. Epub 2015 Nov 9. Pharm Res. 2016. PMID: 26553351 Free PMC article.
-
Biomaterials for Hemostasis.Annu Rev Biomed Eng. 2022 Jun 6;24:111-135. doi: 10.1146/annurev-bioeng-012521-101942. Epub 2022 Mar 1. Annu Rev Biomed Eng. 2022. PMID: 35231178 Free PMC article. Review.
-
Design of polymeric nanoparticles for biomedical delivery applications.Chem Soc Rev. 2012 Apr 7;41(7):2545-61. doi: 10.1039/c2cs15327k. Epub 2012 Feb 14. Chem Soc Rev. 2012. PMID: 22334259 Free PMC article. Review.
-
Strategic approaches for enhancement of in vivo transbuccal peptide drug delivery in rabbits using iontophoresis and chemical enhancers.Pharm Res. 2015 Mar;32(3):929-40. doi: 10.1007/s11095-014-1507-z. Epub 2014 Sep 18. Pharm Res. 2015. PMID: 25231009
-
RNA interference-based nanosystems for inflammatory bowel disease therapy.Int J Nanomedicine. 2016 Oct 12;11:5287-5310. doi: 10.2147/IJN.S116902. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27789943 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical